Figure 1.
Figure 2.
Figure 3.
Association of viral infection with the severity of asthma exacerbation
| Severity of asthma exacerbation | Virus-positive | Virus-negative | P-value |
|---|---|---|---|
| Mild-moderate | 7 (46.7%) | 26 (76.5%) | 0.053 |
| Severe | 8 (53.3%) | 8 (23.5%) |
Profile viral infection in asthma exacerbation
| Respiratory virus | Frequency | % |
|---|---|---|
| RV | 12 | 24.6 |
| Coronavirus | 1 | 2.0 |
| Parainfluenza virus 3 | 1 | 2.0 |
| Coronavirus and RV | 1 | 2.0 |
| Total | 15 | 30.6 |
| Negative | 34 | 69.4 |
Characteristics of the research subject
| Variable | Virus-positive (n = 15) | Virus-negative (n = 34) | P-value |
|---|---|---|---|
| Age (years) | 37.33 ± 15.76 | 45.91 ± 12.48 | 0.067 |
| Gender | 0.174 | ||
| Male | 2 | 13 | |
| Female | 13 | 22 | |
| Smoking | 0.145 | ||
| Yes | 1 | 9 | |
| No | 14 | 25 | |
| History of allergy | 0.652 | ||
| Yes | 14 | 29 | |
| No | 1 | 5 | |
| Duration of asthma (years) | 0.538 | ||
| <20 | 8 | 7 | |
| >20 | 14 | 20 | |
| Asthma control | |||
| Partially controlled | 5 | 10 | 30.6% |
| Uncontrolled | 10 | 24 | 69.4% |
| Comorbidities | |||
| DM | 7 | 1 | |
| Hypertension | 3 | 1 | |
| GERD | 1 | 0 | |